---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-25-002900"
form_type: "8-K"
ticker: "LFWD"
cik: "0001607962"
company_name: "Lifeward Ltd."
filed_at: "2025-08-14T23:59:59+00:00"
generated_at: "2026-05-17T13:12:23.107797+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Lifeward Q2 revenue $5.7M (-15% YoY); net loss $6.6M; resets 2025 guidance

## Summary
- Revenue $5.7M, down 15% YoY; traditional product revenue $2.5M (-19% YoY) excluding one-time Medicare benefit.
- Net loss $6.6M ($0.58 per share) vs $4.3M ($0.50) in Q2 2024; includes $2.8M goodwill impairment.
- Adjusted net loss $3.5M ($0.31 per share); cash burn improved to $3.9M from $5.6M prior year.
- Record number of ReWalk units placed for Medicare since fee schedule; new CEO Mark Grant and CFO Almog Adar appointed.
- FY 2025 guidance reset to revenue $24-26M and non-GAAP net loss $12-14M.

## SEC filing metadata
- accession: 0001178913-25-002900
- form_type: 8-K
- ticker: LFWD
- cik: 0001607962
- company_name: Lifeward Ltd.
- filed_at: 2025-08-14T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1607962/000117891325002900/0001178913-25-002900-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1607962/000117891325002900/zk2533654.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-25-002900
- JSON: https://secwatch.observer/filing/0001178913-25-002900.json
- Plain text: https://secwatch.observer/filing/0001178913-25-002900.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.